Fig. 7From: The efficacy and safety of GLP-1 receptor agonists in youth with type 2 diabetes: a meta-analysisForest plot from meta-analysis models of the impact of GLP-1 RA on (a) nausea, (b) vomiting, (c) diarrhea, and (d) abdominal painBack to article page